- Atlas
- Medicine & Health
- Infectious Diseases
Infectious Diseases
Infectious diseases is the branch of internal medicine that deals with illnesses caused by microorganisms—bacteria, viruses, fungi, protozoa, and helminths—and with the body's response to them.
17 frameworks, from 400 BCE to today · Internal Medicine · Medicine & Health
- Humorism 400 BCE-1850
- Contagionism 1500-1900
- Humoral and Miasmatic Medicine 1500-1880
- Miasma theory 1500-1880
- Vaccinology 1796-Present
- Environmental and vector control 1850-Present
- Germ theory of disease 1861-Present
- Asepsis 1867-Present
- Koch's postulates 1876-Present
- Surveillance and outbreak response 1887-Present
- Antiserum 1890-1945
- Infection prevention and control 1900-Present
- Magic bullet 1909-Present
- Natural-product antibiotic discovery 1940-1990
- Antimicrobial resistance and stewardship 1990-Present
- Molecular diagnostics and genomic epidemiology 1990-Present
- Combination antiviral therapy 1996-Present
Overview
Infectious diseases is the branch of internal medicine that deals with illnesses caused by microorganisms—bacteria, viruses, fungi, protozoa, and helminths—and with the body's response to them. Its practitioners diagnose and treat pneumonia, sepsis, tuberculosis, HIV, malaria, endocarditis, meningitis, and hundreds of other conditions; they also run infection-control programs, steward antibiotic use, and respond to outbreaks. What makes the field distinctive is that its central objects were invisible for most of human history. Physicians could observe fevers, pustules, and contagion's spread, but the causal agents remained speculative until the late nineteenth century. The history of infectious diseases is therefore a history of learning to see: first with better instruments, then with culture media, then with molecular tools—and, alongside each new way of seeing, a new way of intervening.
Humoral Medicine and the Miasma Theory
For roughly two millennia, Western medicine explained epidemic disease through the framework inherited from Hippocratic and Galenic writings. Health depended on the balance of four humors—blood, phlegm, yellow bile, and black bile—and disease arose when that balance was disturbed12. Fevers were understood as the body's effort to expel corrupt matter; treatments aimed to assist that expulsion through bleeding, purging, and diet.
When plagues swept through cities, physicians reached for a second explanation: miasma, or "bad air." The miasma theory held that epidemics arose from foul emanations given off by decaying organic matter, swamps, and crowded unsanitary quarters3. It was not irrational—it correctly identified filth and crowding as correlates of disease—but it located the cause in the air rather than in transmissible agents3. Its practical legacy was sanitary reform: cleaning streets, draining marshes, and improving water supplies. These measures saved lives, though often for reasons their advocates did not fully understand.
Against miasma stood contagionism, the older idea that disease can pass from person to person or through contaminated objects (fomites). Contagionists pointed to the observable spread of smallpox and the apparent effectiveness of quarantine. The two camps competed for centuries, and the debate was not merely academic: it determined whether governments invested in sanitation or in isolation. In practice, many physicians held both views at once, attributing some diseases to air and others to contact.
Smallpox Inoculation and the Birth of Vaccinology
The first great practical breakthrough came from observation rather than theory. In the early eighteenth century, variolation—deliberately inoculating a person with material from a smallpox pustule to produce a mild case and subsequent immunity—was practiced in China, India, the Ottoman Empire, and eventually Europe and the American colonies. It worked, but carried a real risk of causing full-blown smallpox.
In 1796, the English physician Edward Jenner tested a folk belief that milkmaids who had contracted cowpox were protected against smallpox4567. He inoculated a boy with cowpox material and later exposed him to smallpox; the boy remained well45. Jenner published his findings in 1798, and vaccination—named from the Latin vaccinus, "of the cow"—spread internationally457. The principle was profound: a related but milder agent could confer protection against a lethal one. It would take nearly a century for anyone to explain why it worked.
Sanitation, Vectors, and the Environmental Turn
The nineteenth century brought a wave of reforms that reduced infectious disease burden before the agents were known. John Snow's investigation of the 1854 Broad Street cholera outbreak in London—mapping cases and tracing them to a single water pump—demonstrated that cholera was waterborne, contradicting the miasma account. Snow's work is often cited as a founding moment of epidemiology: the use of systematic observation and mapping to identify a source.
Simultaneously, the recognition of insect vectors transformed understanding of diseases like malaria and yellow fever. In 1880, Alphonse Laveran identified the malaria parasite in the blood of patients; in 1897, Ronald Ross showed that mosquitoes transmitted bird malaria, and later work established the Anopheles mosquito as the vector for human malaria. In 1900, Walter Reed's commission in Cuba demonstrated that yellow fever was transmitted by Aedes aegypti mosquitoes. Vector control—draining breeding sites, screening windows, using insecticides—became a cornerstone of public health, and environmental sanitation joined it as a proven strategy against cholera, typhoid, and dysentery.
Germ Theory and the Rise of Bacteriology
The intellectual revolution that unified the field came in the second half of the nineteenth century8. Louis Pasteur's work on fermentation in the 1850s and 1860s showed that microorganisms were responsible for specific chemical processes and could be killed by heat (pasteurization). In 1861, he demonstrated that microbes caused putrefaction. The implication was radical: specific microscopic organisms could cause specific diseases.
Robert Koch gave the new field its method91011. In the 1870s and 1880s, working first on anthrax and then on tuberculosis, Koch developed techniques for growing bacteria in pure culture on solid media—initially using gelatin, then agar—and for staining them. In 1882 he announced the discovery of Mycobacterium tuberculosis; in 1883, the cholera vibrio1012. His "postulates"—criteria for establishing that a particular organism causes a particular disease—became the standard of proof: the organism must be found in all cases of the disease, isolated and grown in pure culture, and reproduce the disease when inoculated into a susceptible host. Koch's postulates were not a single published list but a set of principles articulated across his work; they remain a touchstone, though they have been modified for viruses and for organisms that cannot be cultured11.
The bacteriological revolution produced a rapid succession of discoveries: Neisseria gonorrhoeae (1879), Salmonella typhi (1880), Streptococcus pneumoniae (1881), Corynebacterium diphtheriae (1883), Vibrio cholerae (1883), Clostridium tetani (1884), and many others. Each discovery promised a specific target for prevention or treatment.
Antisepsis and Asepsis
Surgery and childbirth had long been ravaged by infection. In the 1840s, Ignaz Semmelweis observed that women delivered by physicians had far higher rates of puerperal fever than those delivered by midwives, and that handwashing with chlorinated lime reduced mortality dramatically1314. His findings were rejected by much of the medical establishment, and he died in an asylum14.
The decisive change came from Joseph Lister, who in the 1860s applied Pasteur's germ theory to surgery1314. Lister used carbolic acid (phenol) to disinfect wounds, instruments, and the air, and reported striking reductions in postoperative infection. Antisepsis—killing germs after they arrive—was followed by asepsis, the strategy of keeping them out entirely through sterile instruments, gowns, gloves, and operating rooms13. By the early twentieth century, aseptic technique had become standard, and hospital-acquired infections began to be understood as a distinct problem requiring systematic control.
Serotherapy and the Antitoxin Era
The 1890s brought the first effective biological treatments1516. Emil von Behring and Shibasaburo Kitasato showed in 1890 that animals immunized against diphtheria or tetanus produced a substance in their blood—an antitoxin—that could neutralize the toxin and could be transferred to other animals or patients151617. Serum therapy for diphtheria followed, dramatically reducing mortality from a disease that had killed thousands of children each year. The principle—that antibodies from an immune animal could treat disease in another—was the first successful "magic bullet," though it was a biological rather than a chemical one.
The Chemotherapy Revolution and the Magic Bullet
Paul Ehrlich, working in the early twentieth century, pursued the idea of a chemical that would selectively target a pathogen without harming the host—the "magic bullet."1819 In 1909, with Sahachiro Hata, he identified compound 606, salvarsan (arsphenamine), as effective against syphilis. It was toxic and difficult to administer, but it was the first synthetic antimicrobial and proved the principle.
The next major step came from the sulfonamides9. In 1932, Gerhard Domagk at Bayer found that a red dye, prontosil, protected mice against streptococcal infection; the active component was sulfanilamide. Sulfonamides entered clinical use in the mid-1930s and saved lives in cases of puerperal sepsis, meningitis, and pneumonia. For the first time, a pill could cure a bacterial infection.
The Antibiotic Era
In 1928, Alexander Fleming noticed that a mold contaminating a culture plate of staphylococci had killed the bacteria around it. He named the substance penicillin but could not purify it in useful quantities. In the late 1930s and early 1940s, Howard Florey and Ernst Chain at Oxford developed methods to produce and stabilize penicillin, and by 1944 it was being mass-produced for Allied troops2021. Penicillin's effectiveness against streptococci, staphylococci, and other organisms transformed medicine21.
The antibiotic era that followed was driven largely by natural-product discovery: soil bacteria, especially Streptomyces, proved to be a rich source of new compounds. Streptomycin (1943, Selman Waksman's laboratory) was the first effective treatment for tuberculosis. Chloramphenicol, tetracycline, erythromycin, and the cephalosporins followed in the 1940s and 1950s. Each new class expanded the range of treatable infections, and each was greeted with optimism that infectious disease might soon be conquered.
Resistance and Stewardship
That optimism was premature. Fleming himself warned in his 1945 Nobel lecture that misuse of penicillin would select for resistant bacteria. Resistance emerged quickly: penicillin-resistant staphylococci were recognized in hospitals by the late 1940s, and resistance to each new drug followed within years. The mechanisms were diverse—enzymes that destroy the drug (beta-lactamases), altered drug targets, reduced permeability, and efflux pumps that expel the drug from the cell.
By the 1990s and 2000s, multidrug-resistant organisms—MRSA, vancomycin-resistant enterococci, extended-spectrum beta-lactamase-producing gram-negative bacteria, and carbapenem-resistant Enterobacteriaceae—had become major hospital problems. Antimicrobial stewardship emerged as a discipline: the systematic effort to use antibiotics only when needed, at the right dose and duration, to slow resistance and preserve drug efficacy. It combined prescribing guidelines, formulary restrictions, and rapid diagnostics.
Asymptomatic Carriage and Infection Control
A parallel strand of the field concerned patients who carried pathogens without symptoms. The recognition that individuals could harbor and transmit organisms—Salmonella typhi carriers like Mary Mallon ("Typhoid Mary"), who was identified in 1907 and quarantined for decades—made clear that infection control had to account for the invisible carrier. In hospitals, the concept of colonization—organisms present on skin or mucosa without causing disease—became central to understanding how infections spread. Hand hygiene, isolation precautions, and later screening programs for MRSA and other resistant organisms were built on this insight.
Antiviral Therapy and HIV
For most of the twentieth century, viruses resisted chemotherapy because they replicate inside host cells using host machinery. The first effective antivirals targeted herpes and influenza in the 1960s and 1970s, but progress was slow. The HIV epidemic, recognized in 1981, forced a crash program. Zidovudine (AZT), a nucleoside reverse transcriptase inhibitor, was approved in 1987, but monotherapy produced only transient benefit because the virus mutated rapidly.
The turning point was combination antiretroviral therapy (cART), introduced in the mid-1990s22. By combining drugs that targeted different steps in the viral life cycle—reverse transcriptase, protease, and later integrase—clinicians could suppress viral replication below detectable levels and prevent resistance. HIV became a manageable chronic disease rather than a fatal one2223. The same principle—combination therapy to outpace mutation—was later applied to hepatitis C, with direct-acting antivirals achieving cure rates above 90% in the 2010s.
Surveillance and Outbreak Response
The field's population-level arm developed alongside its clinical one. John Snow's cholera investigation was an early model; the founding of national public health agencies—the U.S. Public Health Service's Hygienic Laboratory in 1887 (later the National Institutes of Health), and the Centers for Disease Control in 1946—institutionalized surveillance. The World Health Organization's global influenza surveillance network, established in 1952, and its later eradication campaign against smallpox (1967–1980) demonstrated what coordinated international action could achieve. Smallpox remains the only human infectious disease to have been eradicated246.
The 2014–2016 West African Ebola epidemic and the COVID-19 pandemic exposed both the strengths and the gaps in surveillance and response, and drove investment in genomic sequencing, rapid diagnostics, and vaccine platform technologies.
The Present
Infectious diseases today is a field defined by several converging approaches. Molecular diagnostics—PCR, whole-genome sequencing, and metagenomic sequencing—allow identification of pathogens directly from clinical samples, often within hours. Antimicrobial stewardship and infection prevention remain central, now informed by genomic epidemiology that can trace transmission chains. Vaccinology has moved beyond attenuated and inactivated vaccines to mRNA platforms, deployed at scale during COVID-19. Antiviral combination therapy is standard for HIV and hepatitis C, and is expanding into other viral diseases. And the field continues to grapple with the oldest problems: tuberculosis, malaria, and sepsis remain leading causes of death globally, and the pipeline for new antibiotics is thin. The questions still open are the ones the field has always faced—how to see the invisible, how to kill it without harming the host, and how to stop it from spreading.
References
- Epidemiology (History), Wikipedia
- Humorism (Origin), Wikipedia
- Miasma theory, Wikipedia
- Vaccine (History, introduction), Wikipedia
- Vaccination (History), Wikipedia
- Smallpox vaccine, Wikipedia
- Edward Jenner, Wikipedia
- Germ theory of disease, Wikipedia
- Infection (Germ theory of disease), Wikipedia
- Koch–Pasteur rivalry, Wikipedia
- Koch's postulates, Wikipedia
- Robert Koch, Wikipedia
- Asepsis (History, introduction), Wikipedia
- Ignaz Semmelweis, Wikipedia
- Antiserum (History), Wikipedia
- Antitoxin (History of antitoxin), Wikipedia
- Passive immunity (History and applications of artificial passive immunity), Wikipedia
- Magic bullet (medicine), Wikipedia
- Paul Ehrlich, Wikipedia
- History of penicillin, Wikipedia
- Penicillin, Wikipedia
- Management of HIV/AIDS (History, introduction), Wikipedia
- HIV/AIDS, Wikipedia
- Smallpox, Wikipedia
The frameworks of Infectious Diseases
Each framework is a way of working the field has used: when it held, and the question it answers.
- 400 BCE-1850
- 1500-1900
- 1500-1880
Humoral and Miasmatic Medicine
Do disease come from the body or from the air?
- 1500-1880
- 1796-Present
- 1850-Present
Environmental and vector control
Can cleaning water and killing insects stop disease?
- 1861-Present
Germ theory of disease
Do microscopic organisms cause specific diseases?
- 1867-Present
- 1876-Present
- 1887-Present
Surveillance and outbreak response
How do we detect and track outbreaks as they happen?
- 1890-1945
- 1900-Present
Infection prevention and control
How do hospitals stop infections from spreading inside them?
- 1909-Present
- 1940-1990
Natural-product antibiotic discovery
Can molds and microbes yield drugs that cure infections?
- 1990-Present
Antimicrobial resistance and stewardship
How do we keep antibiotics working as resistance grows?
- 1990-Present
Molecular diagnostics and genomic epidemiology
Can we identify and trace germs by their genes?
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Humoral and Miasmatic Medicine grew out of Humorism
Renaissance physicians inherited the Hippocratic-Galenic four-humors scheme and combined it with the miasma of bad air, so that epidemic disease was explained by both internal humoral imbalance and external corrupt emanations.
Carried by Galen; Hippocratic Corpus.
Asepsis grew out of Germ theory of disease
Lister applied Pasteur's demonstration that microbes cause putrefaction to surgery, using carbolic acid to kill germs in wounds and thereby founding antisepsis, which asepsis then extended.
Carried by Joseph Lister; Louis Pasteur.
Koch's postulates grew out of Germ theory of disease
Koch turned the germ-theory claim that specific microbes cause specific diseases into a method: pure culture, staining and criteria of proof worked out on anthrax and tuberculosis.
Carried by Robert Koch.
Contagionism reacted against Humorism
Contagionism defined itself against the humoral-miasmatic account by holding that disease passes between persons or through fomites rather than arising from internal imbalance or foul air.
Carried by Girolamo Fracastoro.
Germ theory of disease influenced by Contagionism
Contagionist observations that disease spreads from person to person and through contaminated objects supplied the question germ theory answered by identifying specific living agents.
Carried by Girolamo Fracastoro; John Snow.
Environmental and vector control influenced by Miasma theory
Miasma theory's identification of filth, crowding and stagnant water as correlates of disease motivated sanitary reform and environmental measures that later vector and environmental control retained.
Carried by Edwin Chadwick.
Antiserum grew out of Germ theory of disease
Once diphtheria and tetanus were attributed to specific bacterial toxins, Behring and Kitasato immunized animals and transferred the resulting antitoxin to patients.
Carried by Emil von Behring; Shibasaburo Kitasato.
Infection prevention and control grew out of Asepsis
Aseptic technique in surgery and obstetrics was generalised into hospital-wide infection prevention and control programmes once hospital-acquired infection was recognised as a distinct problem.
Magic bullet influenced by Koch's postulates
Ehrlich's programme of systematic chemical screening against a specific cultured organism depended on Koch's methods for identifying and propagating pathogens in the laboratory.
Carried by Paul Ehrlich; Robert Koch.
Molecular diagnostics and genomic epidemiology influenced by Surveillance and outbreak response
Outbreak response adopted whole-genome sequencing to trace transmission chains, extending surveillance from case counts to genomic comparison of isolates.
Natural-product antibiotic discovery grew out of Magic bullet
The magic-bullet ideal of a selectively toxic antimicrobial carried over into the systematic screening of natural products that produced penicillin and streptomycin in clinical use.
Carried by Selman Waksman.
Antimicrobial resistance and stewardship grew out of Natural-product antibiotic discovery
Decades of widespread antibiotic use and the emergence of resistant organisms produced resistance surveillance and stewardship as a corrective to unrestrained natural-product antibiotic discovery and use.
Germ theory of disease influenced by Vaccinology
Jennerian vaccination worked empirically for decades before Pasteur's germ theory supplied the explanation of why a related mild agent confers protection.
Carried by Edward Jenner.
Molecular diagnostics and genomic epidemiology influenced by Koch's postulates
Molecular diagnostics and genomic epidemiology inherit Koch's criterion of identifying a specific causal organism, now by nucleic acid sequence rather than culture.
Magic bullet influenced by Antiserum
Serotherapy's success in neutralizing a pathogen with a biological agent encouraged Ehrlich's search for a chemical that would selectively hit the pathogen, the magic bullet.
Carried by Paul Ehrlich.
Combination antiviral therapy influenced by Magic bullet
The magic-bullet aim of hitting a pathogen selectively at a defined molecular target underlies the design of antiretroviral drugs combined into highly active regimens.
Beyond the field
Where Infectious Diseases's ideas came from in other fields, and what they led to there: the strongest 12 of 119 links.
Contagionism led to Germ theory of disease in Epidemiology
Germ theory is the refinement of contagionism, replacing vague contagion with identified microorganisms as the agents of infectious disease.
Carried by Louis Pasteur; Robert Koch.
Contagionism influenced Germ theory of disease in Public Health
Contagionism supplied germ theory with its central premise of specific transmissible disease agents; Koch, Pasteur and their contemporaries confirmed and transformed the older contagionist idea into a bacteriological doctrine.
Carried by Robert Koch; Louis Pasteur.
Contagionism led to Contagionism and Germ Theory Epidemiology in Epidemiology
The framework is a refinement of contagionism: the older doctrine of contagious transmission was given a specific microbial agent by germ theory.
Contagionism influenced Contagionist State Disease Control in Production Animal Medicine
The contagionist principle that a specific transmissible matter carries disease passed from human medicine, where Fracastoro and later writers had articulated it, into state measures against rinderpest and other epizootics. The European cattle plagues of the eighteenth century prompted administrative controls built on this idea.
Contagionism rival of Miasma theory in Public Health
Contagionism and miasma theory were contemporary rivals over the mechanism of epidemic spread, with contagionists attributing disease to transmissible matter and miasmatists to noxious air.
Humoral and Miasmatic Medicine replaced by Spontaneous Generation Controversy and Germ Theory in Mycology
Germ theory replaced miasmatic and humoral explanations of disease by demonstrating that specific microorganisms cause specific infectious diseases. The earlier framework was rejected as the working explanation.
Carried by Louis Pasteur; Robert Koch.
Miasma theory rival of Contagionism in Public Health
Miasma theory and contagionism were contemporary rival explanations of epidemic disease, competing over whether disease spread by person-to-person contact or by corrupted air.
Vaccinology led to Subunit and conjugate vaccine design in Vaccinology
Submit and conjugate vaccine design is a branch of vaccinology, applying immunological principles to construct defined-antigen vaccines. It grew directly out of the vaccinological programme as antigen identification and purification improved.
Vaccinology led to Platform technology in Vaccinology
Platform technology is a branch of vaccinology: it treats a vaccine production system, such as mRNA or viral vector, as reusable across pathogens. It grew out of vaccine development practice as manufacturing and regulatory experience accumulated.
Vaccinology led to Vaccinology and Viral Disease Control in Virology
Vaccinology and viral disease control is a branch of vaccinology that applies vaccine development and immunisation programmes specifically to viral pathogens. It grew out of the general vaccine tradition once virus culture made viral vaccines feasible.
Carried by John Enders; Thomas Weller; Frederick Robbins.
Vaccinology influenced by Variolation in Vaccinology
Variolation supplied the model and much of the practice Jenner built on: deliberate inoculation of smallpox matter to induce mild disease, which he modified by substituting cowpox lymph.
Carried by Edward Jenner.
Vaccinology led to Correlates of immunity in Vaccinology
Correlates of immunity are a branch of vaccinology, asking which measurable immune responses predict protection after vaccination. The concept grew out of vaccine evaluation practice and remains part of the vaccinological programme.

Infectious Diseases is a planet in Nousfarer
Its city has a tower for each of these 17 frameworks. Land, walk in, and climb one concept at a time.
Land on Infectious DiseasesRelated fields
Fields its ideas are linked to
- Public Health 9 links
- Surveillance And Outbreak Investigation 8 links
- Vaccinology 8 links
- Epidemiology 7 links
- Medical Entomology 5 links
- Bacteriology 4 links
- Public Health Informatics 3 links
- Gastroenterology And Hepatology 3 links
- Tumor Immunology 3 links
- Mycology 3 links
- Virology 3 links
- Pediatric Infectious Diseases 3 links
More in Internal Medicine
- Cardiology
- Dermatology
- Endocrinology And Diabetes
- Gastroenterology And Hepatology
- Geriatric Medicine
- Hematology
- Internal Medicine
- Nephrology
- Pulmonology
- Rheumatology
See where Infectious Diseases sits on the Map of Human Knowledge